4.7 Article

Liver-Secreted Hexosaminidase A Regulates Insulin-Like Growth Factor Signaling and Glucose Transport in Skeletal Muscle

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

AAV gene therapy for Tay-Sachs disease

Terence R. Flotte et al.

Summary: This study presents the results of AAV gene therapy in two patients with infantile TSD. The treatment was well tolerated without vector-related adverse events, and demonstrated an increase and stability of HexA activity in the cerebrospinal fluid. One patient showed disease stabilization, while the other experienced disease progression after treatment.

NATURE MEDICINE (2022)

Article Multidisciplinary Sciences

Deep proteomic profiling unveils arylsulfatase A as a non-alcoholic steatohepatitis inducible hepatokine and regulator of glycemic control

Magdalene K. Montgomery et al.

Summary: Non-alcoholic steatohepatitis (NASH) and type 2 diabetes are closely linked, and this study identifies arylsulfatase A (ARSA) as a regulator that improves muscle insulin sensitivity and systemic glucose control by inhibiting liver secretion of lysophosphatidylcholine and lysophosphatidic acid.

NATURE COMMUNICATIONS (2022)

Article Endocrinology & Metabolism

Circulating cathepsin S improves glycaemic control in mice

Hamzeh Karimkhanloo et al.

Summary: The study reveals a role for CTSS in regulating glycaemic control through direct effects on hepatocytes, leading to improved glucose tolerance and increased plasma insulin in lean mice. CTSS also stimulated GLP-1 secretion without affecting insulin secretion. However, these positive effects of CTSS on glycaemic control are abrogated in insulin resistant states.

JOURNAL OF ENDOCRINOLOGY (2021)

Article Biochemistry & Molecular Biology

Hexosaminidase A (HEXA) regulates hepatic sphingolipid and lipoprotein metabolism in mice

Magdalene K. Montgomery et al.

Summary: Hepatic HexA expression is influenced by lipid availability and steatosis, with overexpression leading to increased hepatic GM3 content and upregulation of enzymes involved in glycated sphingolipid degradation, ultimately resulting in sphingomyelin accumulation in the liver. Additionally, overexpression of HEXA in the liver causes significant changes in cell surface lipid rafts, affecting VLDL processing and secretion, leading to hypertriglyceridemia and ectopic lipid accumulation in peripheral tissues. This study highlights the important role of HEXA in modulating hepatic sphingolipid and lipoprotein metabolism.

FASEB JOURNAL (2021)

Article Multidisciplinary Sciences

Yap regulates skeletal muscle fatty acid oxidation and adiposity in metabolic disease

K. Watt et al.

Summary: Reduced levels of Yap in muscle contribute to the development of obesity and metabolic disease, while increasing Yap abundance in skeletal muscle enhances energy expenditure and reduces adiposity in obese mice.

NATURE COMMUNICATIONS (2021)

Article Cell Biology

SMOC1 is a glucose-responsive hepatokine and therapeutic target for glycemic control

Magdalene K. Montgomery et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Review Endocrinology & Metabolism

The Liver as an Endocrine Organ-Linking NAFLD and Insulin Resistance

Matthew J. Watt et al.

ENDOCRINE REVIEWS (2019)

Review Biochemistry & Molecular Biology

Thirty sweet years of GLUT4

Amira Klip et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2019)

Article Biochemistry & Molecular Biology

Inducible Exoc7/Exo70 knockout reveals a critical role of the exocyst in insulin-regulated GLUT4 exocytosis

Shifeng Wang et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2019)

Article Gastroenterology & Hepatology

Non-alcoholic fatty liver disease - A global public health perspective

Zobair M. Younossi

JOURNAL OF HEPATOLOGY (2019)

Review Endocrinology & Metabolism

IGF1 receptor signaling pathways

Fumihiko Hakuno et al.

JOURNAL OF MOLECULAR ENDOCRINOLOGY (2018)

Review Endocrinology & Metabolism

Setting the stage for a role of the postsynaptic proteome in inherited neurometabolic disorders

Alex Bayes

JOURNAL OF INHERITED METABOLIC DISEASE (2018)

Review Physiology

New Approaches to Tay-Sachs Disease Therapy

Valeriya V. Solovyeva et al.

FRONTIERS IN PHYSIOLOGY (2018)

Review Biotechnology & Applied Microbiology

Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23

Chiara Degirolamo et al.

NATURE REVIEWS DRUG DISCOVERY (2016)

Article Endocrinology & Metabolism

Perilipin 5 is dispensable for normal substrate metabolism and in the adaptation of skeletal muscle to exercise training

Ruzaidi A. M. Mohktar et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2016)

Article Medicine, Research & Experimental

Insulin and IGF-1 receptors regulate FoxO-mediated signaling in muscle proteostasis

Brian T. O'Neill et al.

JOURNAL OF CLINICAL INVESTIGATION (2016)

Article Multidisciplinary Sciences

siRNA-based spherical nucleic acids reverse impaired wound healing in diabetic mice by ganglioside GM3 synthase knockdown

Pratik S. Randeria et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Review Nutrition & Dietetics

Hepatic Steatosis as a Marker of Metabolic Dysfunction

Elisa Fabbrini et al.

NUTRIENTS (2015)

Article Multidisciplinary Sciences

Disparate metabolic response to fructose feeding between different mouse strains

M. K. Montgomery et al.

SCIENTIFIC REPORTS (2015)

Review Developmental Biology

The Fibroblast Growth Factor signaling pathway

David M. Ornitz et al.

WILEY INTERDISCIPLINARY REVIEWS-DEVELOPMENTAL BIOLOGY (2015)

Article Biochemical Research Methods

A miniaturized assay for measuring small molecule phosphorylation in the presence of complex matrices

Christina Spry et al.

ANALYTICAL BIOCHEMISTRY (2014)

Review Endocrinology & Metabolism

FGF21 as a hepatokine, adipokine, and myokine in metabolism and diseases

Nobuyuki Itoh

FRONTIERS IN ENDOCRINOLOGY (2014)

Article Biochemistry & Molecular Biology

Myogenic differentiation and lipid-raft composition of L6 skeletal muscle cells are modulated by PUFAs

Anne Briolay et al.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2013)

Article Medicine, Research & Experimental

N-acetyl-β-D-hexosaminidase in Gestational Diabetes Mellitus - a preliminary study

D. Dudzik et al.

ADVANCES IN MEDICAL SCIENCES (2011)

Review Chemistry, Applied

Structures, Biosynthesis, and Functions of Gangliosides-an Overview

Robert K. Yu et al.

JOURNAL OF OLEO SCIENCE (2011)

Article Biochemistry & Molecular Biology

Obesity causes a shift in metabolic flow of gangliosides in adipose tissues

Aya Tanabe et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)

Article Endocrinology & Metabolism

Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes

Ralph A. DeFronzo et al.

DIABETES CARE (2009)

Article Multidisciplinary Sciences

Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance

Kazuya Kabayama et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Review Biochemistry & Molecular Biology

Gangliosides as components of lipid membrane domains

Sandro Sonnino et al.

GLYCOBIOLOGY (2007)

Article Cardiac & Cardiovascular Systems

β2-adrenergic receptor signaling complexes in cardiomyocyte caveolae/lipid rafts

SE Steinberg

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)

Article Multidisciplinary Sciences

Enhanced insulin sensitivity in mice lacking ganglioside GM3

T Yamashita et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Medical Laboratory Technology

Relationship between plasma ammonia concentration and β-N-acetylhexosaminidase isoenzyme activities in liver cirrhosis

LF Pérez et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2000)

Article Cell Biology

Changes in liver gangliosides in streptozotocin-induced diabetic rats

SS Sanchez et al.

CELL BIOLOGY INTERNATIONAL (2000)